DHR monthly performance report
Check DHR's monthly returns, drawdown, and seasonality trends — updated every month.
DHR monthly report
—
Key takeaways
- Danaher Corporation (DHR) closed September 2026 at $212.50, down 0.50% for the month and +10.14% over the trailing 12 months.
- Year-to-date, DHR is −7.17%, underperforming the S&P 500 which has returned +11.83% YTD.
- The stock is trading +4.86% versus its 200-day moving average ($202.64), a bullish technical signal.
- Over the past three years, DHR has underperformed the S&P 500 by −78.09%, with a relative strength index reading of 54.9.
- Win rate over the trailing 39 months stands at 46.2% — 18 positive months versus 21 negative months.
Danaher Corporation ended September 2026 at $212.50, posting a monthly return of −0.50%. The S&P 500 returned −0.58% over the same window, leaving relative performance at +0.08%.
The current quarter stands at +11.56% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +4.86% versus the 200-day moving average ($202.64).
Year-to-date, DHR is −7.17% against SPY +11.83%, a gap of −19.00%. The stock is currently −12.48% below its 52-week high, with maximum 3-year drawdown at −42.33%.
| Period | DHR | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +1.99% | +1.13% | +0.85% |
| 1 Week | +5.97% | +0.63% | +5.34% |
| 1 Month | −0.50% | −0.58% | +0.08% |
| 3 Months | +17.34% | +1.64% | +15.70% |
| 6 Months | +14.09% | +15.15% | −1.06% |
| YTD | −7.17% | +11.83% | −19.00% |
| 12 Months | +10.14% | +15.69% | −5.55% |
| 3 Years | −6.09% | +72.00% | −78.09% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2023 | +16.30% |
| #2 | Jul 2024 | +10.90% |
| #3 | Aug 2026 | +9.53% |
| #4 | Oct 2025 | +8.64% |
| #5 | Jul 2023 | +6.27% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2023 | −12.70% |
| #2 | Oct 2024 | −11.64% |
| #3 | Mar 2026 | −9.99% |
| #4 | Feb 2025 | −6.73% |
| #5 | Sep 2023 | −6.38% |
| Quarter | Return |
|---|---|
| Q2 2025 | −3.64% |
| Q3 2025 | +0.36% |
| Q4 2025 | +15.46% |
| Q1 2026 | −17.18% |
| Q2 2026 | +0.46% |
| Q3 2026 (QTD) | +11.56% |
| Year | Return |
|---|---|
| 2023 | −1.68% |
| 2024 | −0.77% |
| 2025 | −0.27% |
| 2026 | −7.17% |
| Metric | Value |
|---|---|
| 52-Week High | $242.80 (2026-01-22) |
| 52-Week Low | $160.93 (2026-05-15) |
| Current Price | $212.50 |
| 200-Day Moving Average | $202.64 |
| Price vs 200DMA | +4.86% |
| 3-Year Maximum Drawdown | −42.33% (2026-05-15) |
| Current Drawdown from 52W High | −12.48% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 54.9 |
| 3-Year Excess Return vs S&P 500 | −78.09% |
| RS Peak | 102.6 (Aug 2024) |
| RS Trough | 43.2 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was DHR's return for this report period?
DHR returned −0.50% in the latest monthly window ending 2026-09-17.
Has DHR outperformed SPY year to date?
YTD DHR: −7.17% vs SPY: +11.83%.
What is DHR's 12-month return?
+10.14% over the trailing 12 months.
Is DHR above or below its 200-day moving average?
Price is +4.86% versus 200DMA ($202.64).
What is the maximum drawdown in the 3-year window?
−42.33% on 2026-05-15.